As of 2025-11-03, the Intrinsic Value of Vincerx Pharma Inc (VINC) is -89.77 USD. This VINC valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.10 USD, the upside of Vincerx Pharma Inc is -89,874.50%.
Based on its market price of 0.10 USD and our intrinsic valuation, Vincerx Pharma Inc (VINC) is overvalued by 89,874.50%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -89.77 - -89.77 | -89.77 | -89,874.50% |
| P/E | (222.64) - (309.90) | (277.40) | -277504.0% |
| DDM - Stable | (109.82) - (318.62) | (214.22) | -214321.7% |
| DDM - Multi | (88.66) - (211.75) | (126.33) | -126425.8% |
| Market Cap (mil) | 0.17 |
| Beta | -2.11 |
| Outstanding shares (mil) | 1.67 |
| Enterprise Value (mil) | -4.82 |
| Market risk premium | 4.60% |
| Cost of Equity | 12.26% |
| Cost of Debt | 5.00% |
| WACC | 7.96% |